Anteilseigner
BML Capital Management LLC (13,25 %) The Vanguard Group, Inc. (6,77 %) BlackRock Fund Advisors (6,75 %) D. E. Shaw & Co. LP (4,63 %) Millennium Management LLC (4,62 %) Bain Capital Life Sciences LP (4,23 %) OrbiMed Advisors Private Equity (3,89 %) Rock Springs Capital Management LP (3,88 %) Acadian Asset Management LLC (3,01 %) Renaissance Technologies LLC (2,36 %) Geode Capital Management LLC (2,21 %) Two Sigma Advisers LP (2,05 %) SSgA Funds Management, Inc. (1,89 %) Two Sigma Investments LP (1,87 %) Qube Research & Technologies Ltd. (1,71 %) DWS Investments (UK) Ltd. (1,34 %) Vivo Capital LLC (1,27 %) Citadel Securities LLC (1,19 %) Samsara Biocapital LLC (0,98 %)
Kontakt
Aclaris Therapeutics Inc.